Episode 550: SGLT2 inhibitors ("-flozin" meds) improve all-cause and CV mortality in patients regardless of diabetes or HF status

POEM of the Week Podcast - Un pódcast de Mark Ebell and Michael Wilkes

Categorías:

Ciencia y medicina

Dr. Ebell and Dr. Wilkes discuss the POEM titled ' SGLT2 inhibitors ("-flozin" meds) improve all-cause and CV mortality in patients regardless of diabetes or HF status '

Visit the podcast's native language site